BBCvsPSCHETF Comparison
Virtus LifeSci Biotech Clinical Trials ETF (BBC) belongs to the Tomorrow's Treatments segment. Invesco S&P SmallCap Health Care ETF (PSCH) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Healthcare. BBC is more expensive with a Total Expense Ratio (TER) of 0.65%, versus 0.29% for PSCH. BBC is up 28.23% year-to-date (YTD) with +$5M in YTD flows. PSCH performs worse with 20.01% YTD performance, and -$10M in YTD flows. Run a side-by-side ETF comparison of BBC and PSCH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
BBC vs PSCH performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBC PSCH | -5.49%+1.16% | +8.79%+17.86% | +28.23%+20.01% | +126.14%+35.45% | +122.92%+21.50% | +14.49%-15.34% |
| Flows | BBC PSCH | +$83K+$2M | +$5M+$9M | +$5M-$10M | +$11M-$12M | +$15M-$133M | +$6M-$230M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBC PSCH | +38.48%+17.28% | +35.85%+20.10% | +37.04%+21.87% | +39.65%+22.90% |
| Max drawdown | BBC PSCH | -11.52%-2.96% | -14.64%-15.36% | -54.25%-22.80% | -70.93%-46.32% |
| Max drawdown duration | BBC PSCH | 44d20d | 60d168d | 340d488d | 1754d1789d |
BBC | PSCH | |
Last sale 7/27/2026 at 7:57 PM | $49.74 | $53.21 |
| Previous close 07/27/2026 | $49.67 | $52.91 |
| Consolidated volume 07/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
BBC | PSCH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
BBC | PSCH | |
|---|---|---|
| Last price | $49.74 | $53.21 |
| 1D performance | +0.14% | +0.56% |
| AuM | $47.12 M | $162.43 M |
| E/R | 0.65% | 0.29% |
BBC | PSCH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VIRTUS Investment Partners | Invesco |
| Benchmark | LifeSci Biotechnology Clinical Trials Index | S&P SmallCap 600 Capped Health Care Index |
| N° of holdings | 125 | 75 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | April 7, 2010 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
